US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist
  • 12.250
  • +0.090+0.74%
Close Jul 3 13:00 ET
  • 12.250
  • 0.0000.00%
Post 13:22 ET
781.83MMarket Cap-2728P/E (TTM)

Viridian Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jul 3, 2024

Based on 15 analysts giving stock ratings to Viridian Therapeutics in the past 3 months

Strong Buy

  • Buy

    86.67%

  • Hold

    13.33%

  • Sell

    0.00%

Price Target

Updated: Jul 3, 2024

The average Viridian Therapeutics stock price target is 33.08 with a max estimate of 46.00 and a min estimate of 20.00

Review Viridian Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Jul 3, 2024

Strong Buy

  • Buy

    86.67%

  • Hold

    13.33%

  • Sell

    0.00%

Price Target

Updated: Jul 3, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg